Return On Equity of Mersana Therapeutics, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Mersana Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • Mersana Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 183%.
  • Mersana Therapeutics, Inc. annual Return On Equity for 2024 was -990%, a 251% decline from 2023.
  • Mersana Therapeutics, Inc. annual Return On Equity for 2023 was -282%, a 58% decline from 2022.
  • Mersana Therapeutics, Inc. annual Return On Equity for 2022 was -179%, a 76% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Mersana Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 183% +585% 01 Jul 2025 30 Sep 2025
Q2 2025 320% +654% 01 Apr 2025 30 Jun 2025
Q1 2025 958% +1219% 01 Jan 2025 31 Mar 2025
Q4 2024 -990% -708% -251% 01 Oct 2024 31 Dec 2024
Q3 2024 -401% -137% -52% 01 Jul 2024 30 Sep 2024
Q2 2024 -334% -78% -30% 01 Apr 2024 30 Jun 2024
Q1 2024 -261% -37% -16% 01 Jan 2024 31 Mar 2024
Q4 2023 -282% -104% -58% 01 Oct 2023 31 Dec 2023
Q3 2023 -264% -93% -54% 01 Jul 2023 30 Sep 2023
Q2 2023 -256% -115% -82% 01 Apr 2023 30 Jun 2023
Q1 2023 -224% -105% -88% 01 Jan 2023 31 Mar 2023
Q4 2022 -179% -77% -76% 01 Oct 2022 31 Dec 2022
Q3 2022 -171% -94% -122% 01 Jul 2022 30 Sep 2022
Q2 2022 -141% -83% -142% 01 Apr 2022 30 Jun 2022
Q1 2022 -119% -75% -168% 01 Jan 2022 31 Mar 2022
Q4 2021 -101% -58% -136% 01 Oct 2021 31 Dec 2021
Q3 2021 -77% -32% -71% 01 Jul 2021 30 Sep 2021
Q2 2021 -58% -3% -5.7% 01 Apr 2021 30 Jun 2021
Q1 2021 -44% +34% +43% 01 Jan 2021 31 Mar 2021
Q4 2020 -43% -15% -54% 01 Oct 2020 31 Dec 2020
Q3 2020 -45% -4% -9.8% 01 Jul 2020 30 Sep 2020
Q2 2020 -55% -4% -7.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -78% -21% -36% 01 Jan 2020 31 Mar 2020
Q4 2019 -28% +155% +85% 01 Oct 2019 31 Dec 2019
Q3 2019 -41% +69% +63% 01 Jul 2019 30 Sep 2019
Q2 2019 -51% +21% +30% 01 Apr 2019 30 Jun 2019
Q1 2019 -57% +67% +54% 01 Jan 2019 31 Mar 2019
Q4 2018 -182% 01 Oct 2018 31 Dec 2018
Q3 2018 -110% 01 Jul 2018 30 Sep 2018
Q2 2018 -73% 01 Apr 2018 30 Jun 2018
Q1 2018 -124% 01 Jan 2018 31 Mar 2018

Mersana Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -990% -708% -251% 01 Jan 2024 31 Dec 2024
2023 -282% -104% -58% 01 Jan 2023 31 Dec 2023
2022 -179% -77% -76% 01 Jan 2022 31 Dec 2022
2021 -101% -58% -136% 01 Jan 2021 31 Dec 2021
2020 -43% -15% -54% 01 Jan 2020 31 Dec 2020
2019 -28% +155% +85% 01 Jan 2019 31 Dec 2019
2018 -182% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.